Correlation Between Duopharma Biotech and Lysaght Galvanized

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Duopharma Biotech and Lysaght Galvanized at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Duopharma Biotech and Lysaght Galvanized into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Duopharma Biotech Bhd and Lysaght Galvanized Steel, you can compare the effects of market volatilities on Duopharma Biotech and Lysaght Galvanized and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Duopharma Biotech with a short position of Lysaght Galvanized. Check out your portfolio center. Please also check ongoing floating volatility patterns of Duopharma Biotech and Lysaght Galvanized.

Diversification Opportunities for Duopharma Biotech and Lysaght Galvanized

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Duopharma and Lysaght is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Duopharma Biotech Bhd and Lysaght Galvanized Steel in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lysaght Galvanized Steel and Duopharma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Duopharma Biotech Bhd are associated (or correlated) with Lysaght Galvanized. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lysaght Galvanized Steel has no effect on the direction of Duopharma Biotech i.e., Duopharma Biotech and Lysaght Galvanized go up and down completely randomly.

Pair Corralation between Duopharma Biotech and Lysaght Galvanized

Assuming the 90 days trading horizon Duopharma Biotech Bhd is expected to under-perform the Lysaght Galvanized. But the stock apears to be less risky and, when comparing its historical volatility, Duopharma Biotech Bhd is 6.07 times less risky than Lysaght Galvanized. The stock trades about 0.0 of its potential returns per unit of risk. The Lysaght Galvanized Steel is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  166.00  in Lysaght Galvanized Steel on August 31, 2024 and sell it today you would earn a total of  117.00  from holding Lysaght Galvanized Steel or generate 70.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.91%
ValuesDaily Returns

Duopharma Biotech Bhd  vs.  Lysaght Galvanized Steel

 Performance 
       Timeline  
Duopharma Biotech Bhd 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Duopharma Biotech Bhd are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Duopharma Biotech is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Lysaght Galvanized Steel 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Lysaght Galvanized Steel are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Lysaght Galvanized disclosed solid returns over the last few months and may actually be approaching a breakup point.

Duopharma Biotech and Lysaght Galvanized Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Duopharma Biotech and Lysaght Galvanized

The main advantage of trading using opposite Duopharma Biotech and Lysaght Galvanized positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Duopharma Biotech position performs unexpectedly, Lysaght Galvanized can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lysaght Galvanized will offset losses from the drop in Lysaght Galvanized's long position.
The idea behind Duopharma Biotech Bhd and Lysaght Galvanized Steel pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings